Ann: Phosphagenics and Mylan Agree Settlement, page-44

Hey Col

Good points I reckon re having Future uncertainties closed off to provide some stability for potential partners etc. 

I learnt obviously u not get anywhere with some but hey 

Probs the simplest way I look at it is if Mylan and Strides both had costs of upwards $10m+ combined (Ann does indicate Strides def had up to $5m as per the clause re discounted upfronts etc on any future dealings as a deferred payment in my mind so can assume Mylan similar) yet both Strides and Mylan have forgone those costs in a renegotiated arrangement and have essentially attached a potential indicative value to TPM of at least equal to the costs forgone imo. 

If they did bury POH and could only get a fraction of their costs, I don't buy that was a driving factor in the negotiations personally. If considered that way and if TPM is a total crock and worthless then regardless they will never get anything back in the future so why not just close it out now while have the chance. Why agree to potentials down the track? 

As for the MRA, yep gone but that is research and obv Mylan just said we don't want to fund research side for POH (can do its own in-house)....the licencing agreements are still there though so value still "if" anything proceeds on that track. 

To still be alive, trading, cash for near term, other irons out there as someone else posted just says there is something still.

6mth window is critical though imo, management need to lock down some opportunities in that window. Like to see some updates re EFSA and Triveritas near term as well as per my prev post the other day. 

See what happens.